Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response
Byong-Su Jang, Hyeran Kim, Shinn-Won Lim, Ki-Won Jang, Doh-Kwan Kim
Psychiatry Investig. 2008;5(3):193-198.   Published online 2008 Sep 30     DOI: https://doi.org/10.4306/pi.2008.5.3.193
Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia
Takashi Ishii, Kotaro Hattori, Tomoko Miyakawa, Kentaro Watanabe, Shinsuke Hidese, Daimei Sasayama, Miho Ota, Toshiya Teraishi, Hiroaki Hori, Sumiko Yoshida, Akihiko Nunomura, Kazuyuki Nakagome, Hiroshi Kunugi
Biochemical and Biophysical Research Communication.2018; 497(2): 683.     CrossRef
Does S100B have a potential role in affective disorders? A literature review
Hilda Kroksmark, Maj Vinberg
Nordic Journal of Psychiatry.2018; : 1.     CrossRef
Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B
Chun-Xiao Dai, Chang-Chun Hu, Yu-Shan Shang, Jian Xie
Medicine.2018; 97(39): e12421.     CrossRef
S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression
Oliver Ambrée, Veerle Bergink, Laura Grosse, Judith Alferink, Hemmo A. Drexhage, Matthias Rothermundt, Volker Arolt, Tom K. Birkenhäger
International Journal of Neuropsychopharmacology.2016; 19(3): pyv103.     CrossRef
Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder
Meng-Chang Tsai, Tiao-Lai Huang
Psychiatry Research.2016; 235: 38.     CrossRef
Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder
Frank Martin Schmidt, Roland Mergl, Barbara Stach, Ina Jahn, Peter Schönknecht
The World Journal of Biological Psychiatry.2015; 16(2): 106.     CrossRef
Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers
Bhautesh D. Jani, Gary McLean, Barbara I. Nicholl, Sarah J. E. Barry, Naveed Sattar, Frances S. Mair, Jonathan Cavanagh
Frontiers in Human Neuroscience.2015;[Epub]     CrossRef
Blood Levels of S-100 Calcium-Binding Protein B, High-Sensitivity C-Reactive Protein, and Interleukin-6 for Changes in Depressive Symptom Severity after Coronary Artery Bypass Grafting: Prospective Cohort Nested within a Randomized, Controlled Trial
Daniel M. Pearlman, Jeremiah R. Brown, Todd A. MacKenzie, Felix Hernandez, Souhel Najjar, Malú G. Tansey
PLoS ONE.2014; 9(10): e111110.     CrossRef
S100B overexpression increases behavioral and neural plasticity in response to the social environment during adolescence
Jens Buschert, Christa Hohoff, Chadi Touma, Rupert Palme, Matthias Rothermundt, Volker Arolt, Weiqi Zhang, Oliver Ambrée
Journal of Psychiatric Research.2013; 47(11): 1791.     CrossRef
Neurobiology of Major Depressive Disorder
Rosa Villanueva
Neural Plasticity.2013; 2013: 1.     CrossRef
Blood-brain barrier dysfunction in brain diseases: Clinical experience
Karl Schoknecht, Hadar Shalev
Epilepsia.2012; 53: 7.     CrossRef
Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease
Jwa-Kyung Kim, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song
Clinical Biochemistry.2012; 45(18): 1573.     CrossRef